387 related articles for article (PubMed ID: 25941082)
1. Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis.
Marone G; Varricchi G; Loffredo S; Granata F
Eur J Pharmacol; 2016 May; 778():146-51. PubMed ID: 25941082
[TBL] [Abstract][Full Text] [Related]
2. Innate effector cells in angiogenesis and lymphangiogenesis.
Varricchi G; Loffredo S; Galdiero MR; Marone G; Cristinziano L; Granata F; Marone G
Curr Opin Immunol; 2018 Aug; 53():152-160. PubMed ID: 29778674
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and lymphangiogenesis in inflammatory skin disorders.
Varricchi G; Granata F; Loffredo S; Genovese A; Marone G
J Am Acad Dermatol; 2015 Jul; 73(1):144-53. PubMed ID: 25922287
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis, lymphangiogenesis and atopic dermatitis.
Genovese A; Detoraki A; Granata F; Galdiero MR; Spadaro G; Marone G
Chem Immunol Allergy; 2012; 96():50-60. PubMed ID: 22433371
[TBL] [Abstract][Full Text] [Related]
8. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Lohela M; Bry M; Tammela T; Alitalo K
Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.
Poto R; Loffredo S; Palestra F; Marone G; Patella V; Varricchi G
Cells; 2022 May; 11(10):. PubMed ID: 35626756
[TBL] [Abstract][Full Text] [Related]
10. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
11. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis and lymphangiogenesis in bronchial asthma.
Detoraki A; Granata F; Staibano S; Rossi FW; Marone G; Genovese A
Allergy; 2010 Aug; 65(8):946-58. PubMed ID: 20415716
[TBL] [Abstract][Full Text] [Related]
13. Immune cells as a source and target of angiogenic and lymphangiogenic factors.
Loffredo S; Staiano RI; Granata F; Genovese A; Marone G
Chem Immunol Allergy; 2014; 99():15-36. PubMed ID: 24217601
[TBL] [Abstract][Full Text] [Related]
14. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation.
Watari K; Nakao S; Fotovati A; Basaki Y; Hosoi F; Bereczky B; Higuchi R; Miyamoto T; Kuwano M; Ono M
Biochem Biophys Res Commun; 2008 Dec; 377(3):826-31. PubMed ID: 18951870
[TBL] [Abstract][Full Text] [Related]
15. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
16. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression.
Scavelli C; Vacca A; Di Pietro G; Dammacco F; Ribatti D
Leukemia; 2004 Jun; 18(6):1054-8. PubMed ID: 15057248
[TBL] [Abstract][Full Text] [Related]
18. Expression and functions of the vascular endothelial growth factors and their receptors in human basophils.
de Paulis A; Prevete N; Fiorentino I; Rossi FW; Staibano S; Montuori N; Ragno P; Longobardi A; Liccardo B; Genovese A; Ribatti D; Walls AF; Marone G
J Immunol; 2006 Nov; 177(10):7322-31. PubMed ID: 17082651
[TBL] [Abstract][Full Text] [Related]
19. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
20. Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation.
Crivellato E; Travan L; Ribatti D
Int Arch Allergy Immunol; 2010; 151(2):89-97. PubMed ID: 19752562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
